Delivery Order SPE2DB22D3011-SPE2DB25FQ0FS

Award Date 4/7/25
Potential Completion Date 4/8/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,388.95 and is for the delivery of "LUBRICANT 0.5% EYE DROP 30S". The contract is a Firm Fixed Price Delivery Order with a completion date of March 6, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,499.17 Firm Fixed Price Delivery Order is for the supply of "LUBRICANT 0.5% EYE DROP 30S" and has an ultimate completion date of April 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, with ID SPE2DB20D3303|SPE2DB25FZ5L3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,562.97 firm fixed-price delivery order is for the supply of "LUBRICANT 0.5% EYE DROP 30S" and has an ultimate completion date of April 11, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00...
This federal contract award is for the delivery of 0.5% eye drop lubricant, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,209.60 firm-fixed-price delivery order has a completion date of December 3, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,343.68 firm-fixed-price delivery order is for the supply of 4566133862 LUBRICANT 0.5% EYE DROP 30S, with an ultimate completion date of October 18, 2024. The award is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,677.37 firm-fixed-price delivery order is for the supply of 0.5% eye drop lubricant in 30-count packages. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. It is a firm-fixed-price delivery order valued at $1,980.15 for the supply of LUBRICANT 0.5% EYE DROP 30S. The contract has an ultimate completion date of October 16, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a significant supplier of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,559.44 firm fixed-price delivery order is for the supply of "LUBRICATING PLUS 0.5% EYE DRPS 30S" pharmaceutical products. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This firm fixed-price delivery order, valued at $1,404.70, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for the supply of 0.5% lubricant eye drops in 30-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,352.18 firm fixed-price delivery order is for the supply of 0.5% Lubricant Eye Drops in 30-second doses. The contract has an ultimate completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other federal agencies, including a $999,999,999...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FQ0FS
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under Contract SPE2DB22D3011 valued at $2,115.84. The award is for the provision of "LUBRICANT 0.5% EYE DROP 30S" to the Defense Logistics Agency (DLA), a defense agency. This contract is not designated as a set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/7/25, 1:00 PM